Renewable Energy Financing Update: What Has Changed and What Hasn’t in Financing Renewables
16 April 2020
Foley Partner Thomas Hoffmann, member of the firm’s Energy Industry Team, moderated an Infocast webinar on “Renewable Energy Financing Update: What Has Changed and What Hasn’t in Financing Renewables.” He was joined by the following panelists:
- Jeetu Balchandani, Managing Director, Head of Americas and APAC Infrastructure Debt, Blackrock
- Ralph Cho, Co-Head of Power & Infrastructure Finance, North America Investec Group
- Andrew Redinger, Managing Director – Group Head, KeyBank
- Darren Van’t Hof, Managing Director of Environmental Community Capital, U.S. Bank
- Elizabeth Waters, Managing Director, Project Finance – Americas, MUFG
To find out more about this webinar, or to view more of Infocast’s On-Demand Webinars, click here. Note: You may need to login or register to view these materials.
People
Related Insights
24 July 2025
Events
ACI's Inaugural Summit on GLP-1 Law & Policy
Foley partner Kyle Faget, co-chair of the firm’s Medical Devices Area of Focus, is speaking in American Conference Institute’s Inaugural Summit on GLP-1 Law & Policy on July 24.
23 April 2025
Tariff & International Trade Resource
What Every Multinational Company Should Know About…Tariff Strategies for Sell-Side Contracts
With the size and scope of President Trump’s tariffs continuing to shift, this is a critical time for businesses to assess their contracts and determine how increased tariff costs might adversely affect profitability, and whether there are any strategies to mitigate the losses.
22 April 2025
Health Care Law Today
Health Care Marketing: The Seventh Circuit Addresses “Referrals” Under The Anti-Kickback Statute
The case, United States v. Sorenson, addressed whether a Medicare-registered distributor violated the AKS in making payments to advertising, marketing, and manufacturing companies that worked to sell orthopedic braces to Medicare patients. The court held that such payments were not “referrals” within the meaning of the AKS because the payments were made to entities that were neither physicians in a position to refer their patients nor other decisionmakers in positions to “leverage fluid, informal power and influence” over health care decisions.